ProfileGDS4718 / 225821_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 73% 77% 83% 72% 76% 76% 66% 74% 78% 76% 76% 80% 73% 75% 72% 75% 80% 68% 71% 59% 74% 78% 79% 77% 74% 72% 81% 79% 74% 73% 74% 76% 79% 80% 77% 75% 74% 78% 78% 83% 74% 74% 76% 75% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.1236573
GSM549102patient 115, normal, homogenized [OPG study]7.4531477
GSM549104patient 119, normal, homogenized [OPG study]8.2321883
GSM549108patient 138, normal, homogenized [OPG study]6.9904572
GSM549119patient 077, normal, homogenized [OPG study]7.3567476
GSM549133patient 032, cancer, homogenized [OPG study]7.570476
GSM549139patient 042, cancer, homogenized [OPG study]6.5695166
GSM549099patient 107, normal, homogenized [OPG study]7.1965174
GSM549109patient 139, normal, homogenized [OPG study]7.53778
GSM549110patient 046, normal, homogenized [OPG study]7.3403276
GSM549114patient 063, normal, homogenized [OPG study]7.4654276
GSM549122patient 082, normal, homogenized [OPG study]7.8088780
GSM549134patient 033, cancer, homogenized [OPG study]7.1167673
GSM549136patient 036, cancer, homogenized [OPG study]7.3797875
GSM549140patient 044, cancer, homogenized [OPG study]7.0699972
GSM549111patient 047, normal, homogenized [OPG study]7.3964675
GSM549113patient 057, normal, homogenized [OPG study]7.891180
GSM549132patient 031, cancer, homogenized [OPG study]6.7343668
GSM549137patient 038, cancer, homogenized [OPG study]7.0113171
GSM549142patient 047, cancer, homogenized [OPG study]6.1815259
GSM549100patient 110, normal, homogenized [OPG study]7.1525774
GSM549107patient 135, normal, homogenized [OPG study]7.5997378
GSM549115patient 068, normal, homogenized [OPG study]7.8004179
GSM549116patient 072, normal, homogenized [OPG study]7.5559477
GSM549120patient 078, normal, homogenized [OPG study]7.2586774
GSM549131patient 030, cancer, homogenized [OPG study]7.131372
GSM549118patient 074, normal, homogenized [OPG study]7.9744681
GSM549129patient 027, cancer, homogenized [OPG study]7.7272179
GSM549123patient 088, normal, homogenized [OPG study]7.2308874
GSM549124patient 006, cancer, homogenized [OPG study]7.1350173
GSM549126patient 015, cancer, homogenized [OPG study]7.2485174
GSM549128patient 025, cancer, homogenized [OPG study]7.4952176
GSM549103patient 117, normal, homogenized [OPG study]7.5852679
GSM549117patient 073, normal, homogenized [OPG study]7.8466380
GSM549138patient 041, cancer, homogenized [OPG study]7.5576277
GSM549141patient 045, cancer, homogenized [OPG study]7.4344275
GSM549130patient 028, cancer, homogenized [OPG study]7.1920274
GSM549101patient 111, normal, homogenized [OPG study]7.5888478
GSM549105patient 128, normal, homogenized [OPG study]7.5979878
GSM549106patient 134, normal, homogenized [OPG study]8.4294183
GSM549112patient 048, normal, homogenized [OPG study]7.2563474
GSM549125patient 011, cancer, homogenized [OPG study]7.2557474
GSM549127patient 024, cancer, homogenized [OPG study]7.5146576
GSM549135patient 035, cancer, homogenized [OPG study]7.4290175